Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Lung Cancer

  Free Subscription


Articles published in Cancer Sci

Retrieve available abstracts of 94 articles:
HTML format
Text format



Single Articles


    May 2019
  1. SONG L, Ma S, Chen L, Miao L, et al
    The long-term prognostic significance of IL-17 producing T cells in patients with non-small cell lung cancer.
    Cancer Sci. 2019 May 17. doi: 10.1111/cas.14068.
    PubMed     Text format     Abstract available


  2. YU S, Yang D, Ye Y, Liu P, et al
    lncRNA AFAP1-AS1 promotes malignant phenotype through binding with LSD1 and repressing HBP1 in non-small cell lung cancer.
    Cancer Sci. 2019 May 8. doi: 10.1111/cas.14039.
    PubMed     Text format     Abstract available


  3. HINO O, Abe M, Han B, Yan Y, et al
    In commemoration of the 2018 Mataro Nagayo Prize: A road to early diagnosis and monitoring of asbestos-related mesothelioma.
    Cancer Sci. 2019;110:1518-1524.
    PubMed     Text format     Abstract available


  4. TU W, Yang B, Leng X, Pei X, et al
    Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression.
    Cancer Sci. 2019;110:1573-1586.
    PubMed     Text format     Abstract available


  5. SUDO H, Tsuji AB, Sugyo A, Saga T, et al
    Therapeutic efficacy evaluation of radioimmunotherapy with (90) Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma.
    Cancer Sci. 2019;110:1653-1664.
    PubMed     Text format     Abstract available


    April 2019
  6. ANDO A, Hashimoto N, Sakamoto K, Omote N, et al
    Repressive role of stabilized HIF1alpha expression on TGFbeta-induced extracellular matrix production in lung cancer cells.
    Cancer Sci. 2019 Apr 20. doi: 10.1111/cas.14027.
    PubMed     Text format     Abstract available


  7. SAKAI K, Ohira T, Matsubayashi J, Yoneshige A, et al
    Performance of Oncomine Fusion Transcript kit for formalin-fixed, paraffin-embedded lung cancer specimens.
    Cancer Sci. 2019 Apr 10. doi: 10.1111/cas.14016.
    PubMed     Text format     Abstract available


  8. MASUDA N, Ohe Y, Gemma A, Kusumoto M, et al
    Safety and effectiveness of alectinib in a real-world surveillance study in patients with ALK-positive non-small-cell lung cancer in Japan.
    Cancer Sci. 2019;110:1401-1407.
    PubMed     Text format     Abstract available


    March 2019
  9. FURUTA M, Kikuchi H, Shoji T, Takashima Y, et al
    DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail.
    Cancer Sci. 2019 Mar 15. doi: 10.1111/cas.13997.
    PubMed     Text format     Abstract available


  10. WANG L, Li X, Ren Y, Geng H, et al
    Cancer-associated fibroblasts contribute to cisplatin resistance via modulating ANXA3 in lung cancer cells.
    Cancer Sci. 2019 Mar 13. doi: 10.1111/cas.13998.
    PubMed     Text format     Abstract available


  11. GUO R, Li Y, Wang Z, Bai H, et al
    HIF-1alpha and NF-kappaB play important roles in regulating PD-L1 expression by EGFR mutants in non-small cell lung cancer cells.
    Cancer Sci. 2019 Mar 7. doi: 10.1111/cas.13989.
    PubMed     Text format     Abstract available


  12. IEGUCHI K, Maru Y
    Roles of EphA1/A2 and ephrin-A1 in cancer.
    Cancer Sci. 2019;110:841-848.
    PubMed     Text format     Abstract available


  13. NISHIO M, Takahashi T, Yoshioka H, Nakagawa K, et al
    KEYNOTE-025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1-positive advanced non-small-cell lung cancer.
    Cancer Sci. 2019;110:1012-1020.
    PubMed     Text format     Abstract available


  14. ZHA L, Kitamura Y, Kitamura T, Liu R, et al
    Population-based cohort study on health effects of asbestos exposure in Japan.
    Cancer Sci. 2019;110:1076-1084.
    PubMed     Text format     Abstract available


  15. MIYAUCHI E, Matsuda T, Kiyotani K, Low SK, et al
    Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations.
    Cancer Sci. 2019;110:867-874.
    PubMed     Text format     Abstract available


    February 2019
  16. SUKHBAATAR A, Mori S, Saiki Y, Takahashi T, et al
    Lymph node resection induces the activation of tumor cells in the lungs.
    Cancer Sci. 2019;110:509-518.
    PubMed     Text format     Abstract available


  17. YONEDA K, Kuwata T, Chikaishi Y, Mori M, et al
    Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma.
    Cancer Sci. 2019;110:726-733.
    PubMed     Text format     Abstract available


    January 2019
  18. WAHIDUZZAMAN M, Karnan S, Ota A, Hanamura I, et al
    Establishment and characterization of CRISPR/Cas9-mediated NF2(-/-) human mesothelial cell line: Molecular insight into fibroblast growth factor receptor 2 in malignant pleural mesothelioma.
    Cancer Sci. 2019;110:180-193.
    PubMed     Text format     Abstract available


  19. UCHIDA A, Seki N, Mizuno K, Misono S, et al
    Involvement of dual-strand of the miR-144 duplex and their targets in the pathogenesis of lung squamous cell carcinoma.
    Cancer Sci. 2019;110:420-432.
    PubMed     Text format     Abstract available


    December 2018
  20. PAN H, Peng Z, Lin J, Ren X, et al
    Forkhead box C1 boosts triple-negative breast cancer metastasis through activating the transcription of chemokine receptor-4.
    Cancer Sci. 2018;109:3794-3804.
    PubMed     Text format     Abstract available


  21. LIAO M, Liu Q, Li B, Liao W, et al
    A group of long noncoding RNAs identified by data mining can predict the prognosis of lung adenocarcinoma.
    Cancer Sci. 2018;109:4033-4044.
    PubMed     Text format     Abstract available


  22. IWAMA E, Sakai K, Azuma K, Harada D, et al
    Exploration of resistance mechanisms for epidermal growth factor receptor-tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next-generation sequencing.
    Cancer Sci. 2018;109:3921-3933.
    PubMed     Text format     Abstract available


  23. GU MM, Gao D, Yao PA, Yu L, et al
    p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
    Cancer Sci. 2018;109:3783-3793.
    PubMed     Text format     Abstract available


    November 2018
  24. HAYASHI K, Yamamoto N, Nakajima M, Nomoto A, et al
    Clinical Outcomes of Carbon-Ion Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Cancer Sci. 2018 Nov 22. doi: 10.1111/cas.13890.
    PubMed     Text format     Abstract available


  25. NIU L, Song X, Wang N, Xue L, et al
    Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
    Cancer Sci. 2018 Nov 8. doi: 10.1111/cas.13862.
    PubMed     Text format     Abstract available


  26. WATANABE S, Hayashi H, Haratani K, Shimizu S, et al
    Mutational activation of the EGFR down-regulates MHC class I expression via the ERK in non-small cell lung cancer.
    Cancer Sci. 2018 Nov 3. doi: 10.1111/cas.13860.
    PubMed     Text format     Abstract available


  27. KIMURA S, Tanaka K, Harada T, Liu R, et al
    Sensitivity of epidermal growth factor receptor with single or double uncommon mutations to afatinib confirmed by a visual assay.
    Cancer Sci. 2018;109:3657-3661.
    PubMed     Text format     Abstract available


  28. TAKAHASHI Y, Shien K, Tomida S, Oda S, et al
    Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis.
    Cancer Sci. 2018;109:3634-3642.
    PubMed     Text format     Abstract available


  29. KIM IG, Lee JH, Kim SY, Hwang HM, et al
    Hypoxia-inducible transgelin 2 selects epithelial-to-mesenchymal transition and gamma-radiation-resistant subtypes by focal adhesion kinase-associated insulin-like growth factor 1 receptor activation in non-small-cell lung cancer cells.
    Cancer Sci. 2018;109:3519-3531.
    PubMed     Text format     Abstract available


    October 2018
  30. QIU L, Yu Q, Zhou Y, Zheng S, et al
    Functionally impaired Tfh cells induce regulatory B cells and CD14(+) HLA-DR(-) cells differentiation in non-small cell lung cancer.
    Cancer Sci. 2018 Oct 16. doi: 10.1111/cas.13836.
    PubMed     Text format     Abstract available


  31. HONG MJ, Yoo SS, Choi JE, Kang HG, et al
    A functional intronic variant of SLC5A10 affects DRG2 expression and survival outcomes of early-stage non-small cell lung cancer.
    Cancer Sci. 2018 Oct 3. doi: 10.1111/cas.13814.
    PubMed     Text format     Abstract available


  32. ZHAO X, Li X, Zhou L, Ni J, et al
    LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3.
    Cancer Sci. 2018;109:3068-3079.
    PubMed     Text format     Abstract available


  33. KATO Y, Ninomiya K, Ohashi K, Tomida S, et al
    Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions.
    Cancer Sci. 2018;109:3149-3158.
    PubMed     Text format     Abstract available


  34. LIU M, Jiang L, Fu X, Wang W, et al
    Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.
    Cancer Sci. 2018;109:3055-3067.
    PubMed     Text format     Abstract available


  35. MAEMURA K, Watanabe K, Ando T, Hiyama N, et al
    Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma.
    Cancer Sci. 2018;109:3326-3335.
    PubMed     Text format     Abstract available


    September 2018
  36. ZHAO Y, Shao Q, Zhu H, Xu H, et al
    Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability.
    Cancer Sci. 2018;109:2677-2686.
    PubMed     Text format     Abstract available


  37. HIDA T, Seto T, Horinouchi H, Maemondo M, et al
    Phase II study of ceritinib in alectinib-pretreated patients with anaplastic lymphoma kinase-rearranged metastatic non-small-cell lung cancer in Japan: ASCEND-9.
    Cancer Sci. 2018;109:2863-2872.
    PubMed     Text format     Abstract available


  38. YAMAMOTO Y, Miyazato K, Takahashi K, Yoshimura N, et al
    Lung-resident natural killer cells control pulmonary tumor growth in mice.
    Cancer Sci. 2018;109:2670-2676.
    PubMed     Text format     Abstract available


  39. PONGSUCHART M, Kuchimaru T, Yonezawa S, Tran DTP, et al
    Novel lymphoid enhancer-binding factor 1-cytoglobin axis promotes extravasation of osteosarcoma cells into the lungs.
    Cancer Sci. 2018;109:2746-2756.
    PubMed     Text format     Abstract available


    August 2018
  40. XU S, Lam SK, Cheng PN, Ho JC, et al
    Recombinant human arginase induces apoptosis via oxidative stress and cell cycle arrest in small cell lung cancer.
    Cancer Sci. 2018 Aug 28. doi: 10.1111/cas.13782.
    PubMed     Text format     Abstract available


  41. LIU YP, Chen CH, Yen CH, Tung CW, et al
    HIV Tat-TIP30 interaction promotes metastasis by enhancing the nuclear translocation of Snail in lung cancer cell lines.
    Cancer Sci. 2018 Aug 12. doi: 10.1111/cas.13768.
    PubMed     Text format     Abstract available


  42. SATO H, Yamamoto H, Sakaguchi M, Shien K, et al
    Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer.
    Cancer Sci. 2018 Aug 10. doi: 10.1111/cas.13763.
    PubMed     Text format     Abstract available


  43. GONG WJ, Liu JY, Yin JY, Cui JJ, et al
    Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF-kappaB pathway.
    Cancer Sci. 2018;109:2391-2400.
    PubMed     Text format     Abstract available


  44. ZHU Y, Tang L, Zhao S, Sun B, et al
    CXCR4-mediated osteosarcoma growth and pulmonary metastasis is suppressed by MicroRNA-613.
    Cancer Sci. 2018;109:2412-2422.
    PubMed     Text format     Abstract available


    July 2018
  45. LIU M, Zhang H, Li Y, Wang R, et al
    HOTAIR, a long non-coding RNA, is a marker of abnormal cell cycle regulation in lung cancer.
    Cancer Sci. 2018 Jul 26. doi: 10.1111/cas.13745.
    PubMed     Text format     Abstract available


  46. MURAKAMI H, Nokihara H, Hayashi H, Seto T, et al
    Clinical activity of ASP8273 in Asian patients with non-small cell lung cancer with EGFR activating and T790M mutations.
    Cancer Sci. 2018 Jul 4. doi: 10.1111/cas.13724.
    PubMed     Text format     Abstract available


  47. KAWASAKI N, Miwa T, Hokari S, Sakurai T, et al
    Long noncoding RNA NORAD regulates transforming growth factor-beta signaling and epithelial-to-mesenchymal transition-like phenotype.
    Cancer Sci. 2018;109:2211-2220.
    PubMed     Text format     Abstract available


    June 2018
  48. WATANABE M, Kenmotsu H, Ko R, Wakuda K, et al
    Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
    Cancer Sci. 2018 Jun 14. doi: 10.1111/cas.13692.
    PubMed     Text format     Abstract available


  49. QIN T, Huang D, Liu Z, Zhang X, et al
    TNFSF15 promotes lymphatic metastasis via up-regulation of VEGFC in a mouse model of lung cancer.
    Cancer Sci. 2018 Jun 11. doi: 10.1111/cas.13665.
    PubMed     Text format     Abstract available


  50. WANG H, Zhang G
    Endoplasmic reticulum stress-mediated autophagy protects against beta,beta-dimethylacrylshikonin-induced apoptosis in lung adenocarcinoma cells.
    Cancer Sci. 2018;109:1889-1901.
    PubMed     Text format     Abstract available


  51. ALAEE M, Nool K, Pasdar M
    Plakoglobin restores tumor suppressor activity of p53(R175H) mutant by sequestering the oncogenic potential of beta-catenin.
    Cancer Sci. 2018;109:1876-1888.
    PubMed     Text format     Abstract available


  52. FENG W, Xie Q, Liu S, Ji Y, et al
    Kruppel-like factor 4 promotes c-Met amplification-mediated gefitinib resistance in non-small-cell lung cancer.
    Cancer Sci. 2018;109:1775-1786.
    PubMed     Text format     Abstract available


    May 2018
  53. AZUMA K, Nishio M, Hayashi H, Kiura K, et al
    ASP8273 tolerability and antitumor activity in TKI-naive Japanese patients with EGFR mutation-positive non-small cell lung cancer.
    Cancer Sci. 2018 May 28. doi: 10.1111/cas.13651.
    PubMed     Text format     Abstract available


  54. LI S, Ma F, Jiang K, Shan H, et al
    Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 promotes lung adenocarcinoma by directly interacting with specificity protein 1.
    Cancer Sci. 2018;109:1346-1356.
    PubMed     Text format     Abstract available


  55. LIU K, Gao H, Wang Q, Wang L, et al
    Hispidulin suppresses cell growth and metastasis by targeting PIM1 through JAK2/STAT3 signaling in colorectal cancer.
    Cancer Sci. 2018;109:1369-1381.
    PubMed     Text format     Abstract available


  56. SEMBA T, Sugihara E, Kamoshita N, Ueno S, et al
    Periostin antisense oligonucleotide suppresses bleomycin-induced formation of a lung premetastatic niche for melanoma.
    Cancer Sci. 2018;109:1447-1454.
    PubMed     Text format     Abstract available


  57. HAYASHI K, Yamamoto N, Karube M, Nakajima M, et al
    Feasibility of carbon-ion radiotherapy for re-irradiation of locoregionally recurrent, metastatic, or secondary lung tumors.
    Cancer Sci. 2018;109:1562-1569.
    PubMed     Text format     Abstract available


    April 2018
  58. AKAMATSU H, Katakami N, Okamoto I, Kato T, et al
    Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small cell lung cancer: AURA3 trial.
    Cancer Sci. 2018 Apr 26. doi: 10.1111/cas.13623.
    PubMed     Text format     Abstract available


  59. WANG Y, Lei L, Zheng YW, Zhang L, et al
    Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and beta-catenin.
    Cancer Sci. 2018 Apr 16. doi: 10.1111/cas.13614.
    PubMed     Text format     Abstract available


  60. TANAKA I, Sato M, Kato T, Goto D, et al
    eIF2beta, a Subunit of Translation-Initiation Factor EIF2, Is a Potential Therapeutic Target for Non-Small Cell Lung Cancer.
    Cancer Sci. 2018 Apr 6. doi: 10.1111/cas.13602.
    PubMed     Text format     Abstract available


    March 2018
  61. WANG N, Song X, Liu L, Niu L, et al
    Circulating exosomes contain protein biomarkers of metastatic non-small-cell lung cancer.
    Cancer Sci. 2018 Mar 23. doi: 10.1111/cas.13581.
    PubMed     Text format     Abstract available


  62. TORIGOE H, Shien K, Takeda T, Yoshioka T, et al
    Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations.
    Cancer Sci. 2018 Mar 13. doi: 10.1111/cas.13571.
    PubMed     Text format     Abstract available


    February 2018
  63. XU Y, Ren H, Jiang J, Wang Q, et al
    KIAA0247 inhibits growth, migration, invasion of non-small-cell lung cancer through regulating the Notch pathway.
    Cancer Sci. 2018 Feb 16. doi: 10.1111/cas.13539.
    PubMed     Text format     Abstract available


  64. LI W, Zheng G, Xia J, Yang G, et al
    CREPT overexpression is associated with proliferation behaviors and poor prognosis in non-small cell lung cancer.
    Cancer Sci. 2018 Feb 3. doi: 10.1111/cas.13524.
    PubMed     Text format     Abstract available


  65. OHARA Y, Chew SH, Shibata T, Okazaki Y, et al
    Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats.
    Cancer Sci. 2018;109:330-339.
    PubMed     Text format     Abstract available


  66. LI P, Zhang L, Yu X, Tong R, et al
    Proliferation genes in lung development associated with the prognosis of lung adenocarcinoma but not squamous cell carcinoma.
    Cancer Sci. 2018;109:308-316.
    PubMed     Text format     Abstract available


    January 2018
  67. ZHANG Q, Yang J, Bai J, Ren J, et al
    Reverse of non-small cell lung cancer drug resistance induced by cancer associated fibroblasts via a paracrine pathway.
    Cancer Sci. 2018 Jan 30. doi: 10.1111/cas.13520.
    PubMed     Text format     Abstract available


  68. KIURA K, Yoh K, Katakami N, Nogami N, et al
    Osimertinib in patients with EGFR T790M advanced non-small cell lung cancer selected using cytology samples.
    Cancer Sci. 2018 Jan 24. doi: 10.1111/cas.13511.
    PubMed     Text format     Abstract available


  69. CHARVAT H, Sasazuki S, Shimazu T, Budhathoki S, et al
    Development of a risk prediction model for lung cancer: the Japan Public Health Center-based Prospective Study.
    Cancer Sci. 2018 Jan 18. doi: 10.1111/cas.13509.
    PubMed     Text format     Abstract available


  70. KATAYAMA R
    Drug resistance in anaplastic lymphoma kinase-rearranged lung cancer.
    Cancer Sci. 2018 Jan 16. doi: 10.1111/cas.13504.
    PubMed     Text format     Abstract available


  71. FAZIO N, Buzzoni R, Delle Fave G, Tesselaar ME, et al
    Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis.
    Cancer Sci. 2018;109:174-181.
    PubMed     Text format     Abstract available


    December 2017
  72. CHENG HW, Chein RJ, Cheng TJ, Wu PS, et al
    The 2-anilino-4-amino-5-aroylthiazole-type compound AS7128 inhibits lung cancer growth through decreased iASPP and p53 interaction.
    Cancer Sci. 2017 Dec 29. doi: 10.1111/cas.13489.
    PubMed     Text format     Abstract available


    November 2017
  73. LIU J, Bian T, Feng J, Qian L, et al
    miR-335 inhibited cell proliferation of lung cancer cells by target Tra2beta.
    Cancer Sci. 2017 Nov 21. doi: 10.1111/cas.13452.
    PubMed     Text format     Abstract available


  74. ESAKI N, Ohkawa Y, Hashimoto N, Tsuda Y, et al
    ASCT2 defined by enzyme-mediated activation of radical sources enhances malignancy of GD2-plus small cell lung cancer.
    Cancer Sci. 2017 Nov 19. doi: 10.1111/cas.13448.
    PubMed     Text format     Abstract available


  75. OKABE H, Aoki K, Yogosawa S, Saito M, et al
    Downregulation of CD24 suppresses bone metastasis of lung cancer.
    Cancer Sci. 2017 Nov 2. doi: 10.1111/cas.13435.
    PubMed     Text format     Abstract available


  76. MAGARA K, Takasawa A, Osanai M, Ota M, et al
    Elevated expression of JAM-A promotes neoplastic properties of lung adenocarcinoma.
    Cancer Sci. 2017;108:2306-2314.
    PubMed     Text format     Abstract available


  77. DASSANO A, Pintarelli G, Cotroneo CE, Pettinicchio A, et al
    Complex genetic control of lung tumorigenesis in resistant mice strains.
    Cancer Sci. 2017;108:2281-2286.
    PubMed     Text format     Abstract available


    October 2017
  78. KATSURA M, Shoji F, Okamoto T, Shimamatsu S, et al
    Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.
    Cancer Sci. 2017 Oct 15. doi: 10.1111/cas.13422.
    PubMed     Text format     Abstract available


  79. HUANG LX, Hu CY, Jing L, Wang MC, et al
    microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1.
    Cancer Sci. 2017;108:1985-1995.
    PubMed     Text format     Abstract available


  80. TAKITA J
    The role of anaplastic lymphoma kinase in pediatric cancers.
    Cancer Sci. 2017;108:1913-1920.
    PubMed     Text format     Abstract available


    September 2017
  81. LIU L, Liu J, Shao D, Deng Q, et al
    Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients.
    Cancer Sci. 2017 Sep 26. doi: 10.1111/cas.13410.
    PubMed     Text format     Abstract available


  82. CHI Y, Jin Q, Liu X, Xu L, et al
    The miR-203 inhibits cell proliferation, invasion, and migration of non-small cell lung cancer by downregulating RGS17.
    Cancer Sci. 2017 Sep 16. doi: 10.1111/cas.13401.
    PubMed     Text format     Abstract available


  83. MATSUBARA D, Soda M, Yoshimoto T, Amano Y, et al
    Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.
    Cancer Sci. 2017;108:1888-1896.
    PubMed     Text format     Abstract available


    August 2017
  84. KUTKOWSKA J, Strzadala L, Rapak A
    Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.
    Cancer Sci. 2017 Aug 28. doi: 10.1111/cas.13386.
    PubMed     Text format     Abstract available


  85. INOUE Y, Matsuura S, Yoshimura K, Iwashita Y, et al
    Characterization of V-set and immunoglobulin domain containing 1 exerting a tumor suppressor function in gastric, lung, and esophageal cancer cells.
    Cancer Sci. 2017;108:1701-1714.
    PubMed     Text format     Abstract available


    July 2017
  86. OTSUBO K, Nosaki K, Imamura CK, Ogata H, et al
    Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small cell lung cancer.
    Cancer Sci. 2017 Jul 1. doi: 10.1111/cas.13309.
    PubMed     Text format     Abstract available


  87. GRIESING S, Kajino T, Tai MC, Liu Z, et al
    Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells.
    Cancer Sci. 2017;108:1394-1404.
    PubMed     Text format     Abstract available


  88. KUNIMASA K, Nagano T, Shimono Y, Dokuni R, et al
    Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters.
    Cancer Sci. 2017;108:1368-1377.
    PubMed     Text format     Abstract available


    May 2017
  89. TANIGUCHI H, Yamada T, Takeuchi S, Arai S, et al
    The impact of MET inhibition on small-cell lung cancer cells exhibiting aberrant activation of the HGF/MET pathway.
    Cancer Sci. 2017 May 5. doi: 10.1111/cas.13268.
    PubMed     Text format     Abstract available


    April 2017
  90. WANG R, Deng X, Yoshioka Y, Vougiouklakis T, et al
    Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small cell lung cancer cells.
    Cancer Sci. 2017 Apr 1. doi: 10.1111/cas.13245.
    PubMed     Text format     Abstract available


    March 2017
  91. SATO T, Shiba-Ishii A, Kim Y, Dai T, et al
    miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma.
    Cancer Sci. 2017;108:536-542.
    PubMed     Text format     Abstract available


  92. KUSUMOTO H, Shintani Y, Kanzaki R, Kawamura T, et al
    Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.
    Cancer Sci. 2017;108:528-535.
    PubMed     Text format     Abstract available


    February 2017
  93. KAMIOKA Y, Takakura K, Sumiyama K, Matsuda M, et al
    Intravital Forster resonance energy transfer imaging reveals osteopontin-mediated polymorphonuclear leukocyte activation by tumor cell emboli.
    Cancer Sci. 2017;108:226-235.
    PubMed     Text format     Abstract available


  94. KARASAKI T, Nagayama K, Kuwano H, Nitadori JI, et al
    Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
    Cancer Sci. 2017;108:170-177.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: